AEMD Berita Valas

Aethlon Inks Materials Transfer Deal For Santersus' NucleoCapture And HemoNucleoCapture Devices

Medical therapeutic company Aethlon Medical, Inc. (AEMD) announced Wednesday that it entered into a Materials Transfer Agreement (MTA) with Santersus AG, a Zurich-London based, privately held therapeutic medical device company, for Santersus' NucleoCapture and HemoNucleoCapture devices.

RTTNews | 561 days ago

Terms | Privacy | Site Map | Site Map Calendar

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.

EURUSD	1.16608	GBPUSD	1.34485	AUDUSD	0.65265
USDJPY	148.17	USDCAD	1.38105	USDCHF	0.80487